Article

Proteonano™: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney disease

2023-09-14

Abstract excerpt

<h4>ABSTRACT</h4> The development of blood-based multi-biomarker panels for screening diabetic patients, and as an easy-to-access tool for identifying individuals at greatest risk of developing diabetic kidney disease (DKD) and its progression, is essential. However, conventional blood biomarker-based methodologies (e.g. clinical tests and ELISA) are unable to predict DKD progression with high sensitivity and spe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0aba63c6-2ffb-5d78-aa10-c87cf66474ba
DOI: 10.1101/2023.09.12.556305

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Proteonano™: a novel deep proteomics platform with 1000-plex profiling capacity and picogram sensitivity and its application in diabetic kidney diseaseDOI 10.1101/2023.09.12.556305Read

Results of untargeted analysis using the SOMAscan proteomics platform indicates novel associations of circulating proteins with risk of progression to kidney failure in diabetesSemantic proximity Read

Urine Proteomics Identifies Biomarkers for Diabetic Kidney Disease at Different StagesSemantic proximity Read

Identifying molecular pathways of type 2 diabetes using proteomics, metabolic, and anthropometric profiles in UK and Chinese adultsSemantic proximity Read

Plasma Proteomics of Diabetic Kidney Disease Among Asians With Younger-Onset Type 2 DiabetesSemantic proximity Read

Integrating Genetics and the Plasma Proteome to Predict the Risk of Type 2 DiabetesSemantic proximity Read

Proteomic Profiling of Glucose Metabolism Disturbances Yields Novel Plasma Proteins that May Be Associated With Development or Early Complications of DiabetesSemantic proximity Read

Extracellular vesicle-derived AEBP1 mRNA as a novel candidate biomarker for diabetic kidney diseaseSemantic proximity Read

Perspectives on systems biology applications in diabetic kidney disease.Semantic proximity Read

Omics research in diabetic kidney disease: new biomarker dimensions and new understandings?Semantic proximity Read

Discovering a trans-omics biomarker signature that predisposes high risk diabetic patients to diabetic kidney diseaseSemantic proximity Read

The remarkable similarity in the serum proteome between type 2 diabetics and controlsSemantic proximity Read

Systems biology and machine learning approaches identify drug targets in diabetic nephropathySemantic proximity Read